Defence Therapeutics
(OTC) DTCFF
Defence Therapeutics Financials at a Glance
Market Cap
$22.87MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
CA$0.00
Net Income (TTM)
-CA$6.19M
EPS (TTM)
-$0.08
P/E Ratio
-3.73
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$0.30
Volume
200
Open
$0.30
Price
$0.30
Volume
200
Open
$0.30
Previous Close
$0.30
Daily Range
$0.30 - $0.30
52-Week Range
$0.29 - $0.78
Estimated Earnings Date
Jun 21, 2022
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$0.30
Volume
200
Open
$0.30
Previous Close
$0.30
Daily Range
$0.30 - $0.30
52-Week Range
$0.29 - $0.78
Estimated Earnings Date
Jun 21, 2022
DTCFF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Defence Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Sébastien Plouffe
Website
www.defencetherapeutics.comHeadquarters
Vancouver, BC H4S1Z9, CA
DTCFF Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-1661.38%
Return on Capital
-594.06%
Return on Assets
-67.17%
Earnings Yield
-26.81%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$22.87MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
75.79M
Volume
200
Avg. Volume
7.63K
Financials (TTM)
Gross Profit
-CA$34.98K
Operating Income
-CA$4.44M
EBITDA
-CA$3.40M
Operating Cash Flow
-CA$4.71M
Capital Expenditure
CA$808.83K
Free Cash Flow
-CA$3.73M
Cash & ST Invst.
CA$2.96M
Total Debt
CA$1.57M
Defence Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$0.00
N/A
Gross Profit
-CA$9.45K
N/A
Gross Margin
0.00%
N/A
Market Cap
$22.87MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$17.59K
N/A
Employees
1,300
N/A
Net Income
-CA$2.97M
-211.9%
EBITDA
-CA$1.41M
-65.7%
Quarterly Fundamentals
Total Cash
CA$2.96M
+42.4%
Total Debt
CA$1.57M
+12.6%
Accounts Receivable
CA$316.00K
+259.9%
Inventory
CA$0.00
N/A
Long Term Debt
CA$1.57M
N/A
Short Term Debt
CA$0.00
-100.0%
Return on Assets
-67.17%
N/A
Return on Invested Capital
-53.54%
N/A
Free Cash Flow
-CA$1.59M
+20.2%
Operating Cash Flow
-CA$1.59M
+20.2%